Plasma membrane, Enriched in surface-labeled proteome 11 Uncharacterized
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | yes | yes: 4, no: 2 |
| NetGPI | no | yes: 0, no: 6 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 5 |
| GO:0020016 | ciliary pocket | 2 | 1 |
| GO:0110165 | cellular anatomical entity | 1 | 5 |
Related structures:
AlphaFold database: A4I9S9
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 173 | 175 | PF00675 | 0.433 |
| CLV_PCSK_KEX2_1 | 173 | 175 | PF00082 | 0.433 |
| CLV_PCSK_SKI1_1 | 110 | 114 | PF00082 | 0.544 |
| CLV_PCSK_SKI1_1 | 167 | 171 | PF00082 | 0.443 |
| CLV_PCSK_SKI1_1 | 51 | 55 | PF00082 | 0.714 |
| DOC_CKS1_1 | 221 | 226 | PF01111 | 0.691 |
| DOC_CYCLIN_yCln2_LP_2 | 250 | 253 | PF00134 | 0.630 |
| DOC_PP2B_LxvP_1 | 250 | 253 | PF13499 | 0.630 |
| DOC_PP2B_LxvP_1 | 77 | 80 | PF13499 | 0.408 |
| DOC_USP7_MATH_1 | 176 | 180 | PF00917 | 0.694 |
| DOC_USP7_MATH_1 | 263 | 267 | PF00917 | 0.662 |
| DOC_USP7_MATH_1 | 34 | 38 | PF00917 | 0.498 |
| DOC_WW_Pin1_4 | 215 | 220 | PF00397 | 0.750 |
| LIG_14-3-3_CanoR_1 | 11 | 21 | PF00244 | 0.461 |
| LIG_AP2alpha_2 | 114 | 116 | PF02296 | 0.342 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.576 |
| LIG_BRCT_BRCA1_1 | 195 | 199 | PF00533 | 0.617 |
| LIG_CtBP_PxDLS_1 | 252 | 256 | PF00389 | 0.631 |
| LIG_FHA_1 | 16 | 22 | PF00498 | 0.451 |
| LIG_FHA_1 | 166 | 172 | PF00498 | 0.612 |
| LIG_FHA_1 | 221 | 227 | PF00498 | 0.703 |
| LIG_FHA_1 | 80 | 86 | PF00498 | 0.380 |
| LIG_FHA_2 | 198 | 204 | PF00498 | 0.651 |
| LIG_LIR_Gen_1 | 161 | 171 | PF02991 | 0.679 |
| LIG_LIR_Nem_3 | 144 | 149 | PF02991 | 0.424 |
| LIG_LIR_Nem_3 | 161 | 166 | PF02991 | 0.651 |
| LIG_LYPXL_yS_3 | 248 | 251 | PF13949 | 0.641 |
| LIG_MYND_1 | 111 | 115 | PF01753 | 0.364 |
| LIG_MYND_1 | 249 | 253 | PF01753 | 0.631 |
| LIG_NRBOX | 20 | 26 | PF00104 | 0.509 |
| LIG_Pex14_1 | 159 | 163 | PF04695 | 0.609 |
| LIG_PTB_Apo_2 | 83 | 90 | PF02174 | 0.338 |
| LIG_PTB_Phospho_1 | 83 | 89 | PF10480 | 0.398 |
| LIG_SH2_CRK | 163 | 167 | PF00017 | 0.723 |
| LIG_SH2_GRB2like | 84 | 87 | PF00017 | 0.359 |
| LIG_SH2_NCK_1 | 194 | 198 | PF00017 | 0.676 |
| LIG_SH2_SRC | 84 | 87 | PF00017 | 0.359 |
| LIG_SH2_STAT5 | 150 | 153 | PF00017 | 0.312 |
| LIG_SH2_STAT5 | 84 | 87 | PF00017 | 0.359 |
| LIG_SH2_STAT5 | 89 | 92 | PF00017 | 0.303 |
| LIG_SH3_3 | 175 | 181 | PF00018 | 0.651 |
| LIG_SH3_3 | 203 | 209 | PF00018 | 0.655 |
| LIG_SH3_3 | 210 | 216 | PF00018 | 0.719 |
| LIG_SH3_3 | 218 | 224 | PF00018 | 0.812 |
| LIG_SH3_3 | 243 | 249 | PF00018 | 0.730 |
| LIG_SH3_3 | 46 | 52 | PF00018 | 0.446 |
| LIG_TRFH_1 | 248 | 252 | PF08558 | 0.636 |
| LIG_TYR_ITIM | 246 | 251 | PF00017 | 0.623 |
| MOD_CK1_1 | 141 | 147 | PF00069 | 0.407 |
| MOD_CK1_1 | 211 | 217 | PF00069 | 0.704 |
| MOD_CK1_1 | 38 | 44 | PF00069 | 0.483 |
| MOD_CK2_1 | 197 | 203 | PF00069 | 0.652 |
| MOD_CK2_1 | 234 | 240 | PF00069 | 0.725 |
| MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.664 |
| MOD_GlcNHglycan | 140 | 143 | PF01048 | 0.315 |
| MOD_GlcNHglycan | 195 | 198 | PF01048 | 0.500 |
| MOD_GlcNHglycan | 210 | 213 | PF01048 | 0.444 |
| MOD_GlcNHglycan | 25 | 28 | PF01048 | 0.562 |
| MOD_GlcNHglycan | 93 | 96 | PF01048 | 0.545 |
| MOD_GSK3_1 | 176 | 183 | PF00069 | 0.611 |
| MOD_GSK3_1 | 193 | 200 | PF00069 | 0.661 |
| MOD_GSK3_1 | 211 | 218 | PF00069 | 0.646 |
| MOD_GSK3_1 | 34 | 41 | PF00069 | 0.608 |
| MOD_N-GLC_1 | 38 | 43 | PF02516 | 0.743 |
| MOD_NEK2_1 | 23 | 28 | PF00069 | 0.450 |
| MOD_NEK2_2 | 162 | 167 | PF00069 | 0.594 |
| MOD_OFUCOSY | 103 | 109 | PF10250 | 0.596 |
| MOD_PKA_2 | 13 | 19 | PF00069 | 0.570 |
| MOD_PKA_2 | 47 | 53 | PF00069 | 0.462 |
| MOD_Plk_4 | 125 | 131 | PF00069 | 0.406 |
| MOD_Plk_4 | 79 | 85 | PF00069 | 0.431 |
| MOD_ProDKin_1 | 215 | 221 | PF00069 | 0.751 |
| MOD_SUMO_rev_2 | 37 | 46 | PF00179 | 0.630 |
| TRG_DiLeu_BaLyEn_6 | 246 | 251 | PF01217 | 0.640 |
| TRG_ENDOCYTIC_2 | 163 | 166 | PF00928 | 0.696 |
| TRG_ENDOCYTIC_2 | 248 | 251 | PF00928 | 0.641 |
| TRG_ER_diArg_1 | 172 | 174 | PF00400 | 0.633 |
| TRG_ER_diArg_1 | 245 | 248 | PF00400 | 0.625 |
| TRG_ER_diArg_1 | 99 | 102 | PF00400 | 0.351 |
| TRG_Pf-PMV_PEXEL_1 | 184 | 188 | PF00026 | 0.482 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P5W2 | Leptomonas seymouri | 45% | 100% |
| A0A3S7X7R5 | Leishmania donovani | 100% | 100% |
| A4HAN6 | Leishmania braziliensis | 64% | 100% |
| E9B4U0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 100% |
| Q4Q386 | Leishmania major | 91% | 100% |